Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development expense	$ 49,586	$ 86,129
General and administrative	32,610	37,352
Total operating expenses	82,196	123,481
Loss from operations	(82,196)	(123,481)
Other income, net:
Interest and investment income	6,630	2,764
Sublease income	1,776
Total other income, net	8,406	2,764
Net loss	$ (73,790)	$ (120,717)
Net loss per common share - basic	$ (1.85)	$ (3.65)
Net loss per common share - diluted	$ (1.85)	$ (3.65)
Weighted average shares of common stock outstanding - basic	39,904,603	33,033,081
Weighted average shares of common stock outstanding - diluted	39,904,603	33,033,081
Other comprehensive income:
Net unrealized gain on marketable debt securities	$ 63
Other comprehensive income	63
Comprehensive loss	$ (73,727)	$ (120,717)